Your physician will design a cyclical protocol tailored to your age, health status, aesthetic goals, metabolic health, and longevity objectives
Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
For a 2.5mg (2,500mcg) dose: 2,500 / 5,000 x 100 = 50 units
Aby osign optymalne rezultaty ze stosowania BPC157, zaleca si stosowanie go codziennie przez okres do 3 miesicy, po czym nastpuje jeden do dwch miesicy przerwy
However, after 8 weeks of treatment with intranasal GHK-Cu, when mice were 22 months of age, both males and females showed an increase in alternation percentage